Item 8.01 Other Events.

On May 25, 2021, NeuroOne Medical Technologies Corporation (the "Company") issued a press release announcing that The Nasdaq Stock Market LLC has approved the listing of the Company's common stock on The Nasdaq Capital Market. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

The Company's common stock is expected to commence trading on The Nasdaq Capital Market on May 26, 2021 under the Company's current ticker symbol "NMTC."




Item 9.01.  Financial Statements and Exhibits.



(d)  Exhibits.



99.1   Press Release, dated May 25, 2021.




                                       1

© Edgar Online, source Glimpses